The DOI matches its Crossref record.
DNA End Labeling (TUNEL) in Huntington's Disease and Other Neuropathological Conditions
Open accessAbstract
Deoxyribonucleic acid of cells undergoing apoptosis is cleaved by a calcium-dependent endonuclease into oligonucleosomal-sized fragments. These fragments can be labeled using the enzyme terminal deoxynucleotidyl transferase so that the cells can be visualized immunohistochemically. Few investigators have evaluated this method in disease processes of the human central nervous system. The Tdt-mediated dUTP-biotin nick end labeling (TUNEL) technique has been investigated in preliminary studies of a variety of pathologic conditions of the human brain (e.g., gliomas, traumatic brain injury, Parkinson's disease, Parkinson's-Alzheimer's complex, multisystem atrophy, striatonigral degeneration). We focus, however, on Huntington's disease (HD) because of the availability of well-characterized pathological stages for study, and also because of the neurodegenerative diseases studied to date, only Huntington's disease revealed significant and consistent labeling with this method. This implies a possibly unique nature to the mechanism of cell death in Huntington's disease compared to the other neurodegenerative diseases studied. TUNEL+ neurons were found in Grade 1-4 HD neostriatum, while labeled astrocytes were found predominantly in the Grade 1 and 2 cases studied to date. TUNEL+ cells were also found in glioblastoma multiforme and traumatic brain injury. We conclude that while there appear to be several limitations associated with this technique, it may be useful for identifying both apoptosis and necrosis in certain neuropathological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Apoptosis and Caspases in Neurodegenerative Diseases
Friedlander, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022366 · Cited by 873
Zeitlin, S., Liu, J.-P., Chapman, D. L., Papaioannou, V. E., & Efstratiadis, A. (1995) · Nature Genetics · doi:10.1038/ng1095-155 · Cited by 802
Goldberg, Y. P., Nicholson, D. W., Rasper, D. M., Kalchman, M. A., Koide, H. B., Graham, R. K., Bromm, M., Kazemi-Esfarjani, P., Thornberry, N. A., Vaillancourt, J. P., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-442 · Cited by 581
Clearance of apoptotic cells: implications in health and disease
Elliott, M. R., & Ravichandran, K. S. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201004096 · Cited by 551
Targeting programmed cell death in neurodegenerative diseases
Vila, M., & Przedborski, S. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1100 · Cited by 546
The role of neuronal growth factors in neurodegenerative disorders of the human brain
Connor, B., & Dragunow, M. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00004-6 · Cited by 536
Kukekov, V. G., Laywell, E. D., Suslov, O., Davies, K., Scheffler, B., Thomas, L. B., O'Brien, T. F., Kusakabe, M., & Steindler, D. A. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7028 · Cited by 522
Self-citationMechanisms of neurodegeneration in Huntington’s disease
Gil, J. M., & Rego, A. C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06310.x · Cited by 471
Astrocyte apoptosis: implications for neuroprotection
Takuma, K., Baba, A., & Matsuda, T. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.02.001 · Cited by 435
Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
Turmaine, M., Raza, A., Mahal, A., Mangiarini, L., Bates, G. P., & Davies, S. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110078997 · Cited by 430
Replicating Huntington's disease phenotype in experimental animals
Brouillet, E. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00005-2 · Cited by 413
Is Schizophrenia a Progressive Neurodevelopmental Disorder? Toward a Unitary Pathogenetic Mechanism
Woods, B. T. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.12.1661 · Cited by 412
Reddy, P. H., Williams, M., Charles, V., Garrett, L., Pike-Buchanan, L., Whetsell, W. O., Miller, G., & Tagle, D. A. (1998) · Nature Genetics · doi:10.1038/2510 · Cited by 399
Dugan, L. L., Gabrielsen, J. K., Yu, S. P., Lin, T.-S., & Choi, D. W. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0013 · Cited by 384
Wellington, C. L., Singaraja, R., Ellerby, L., Savill, J., Roy, S., Leavitt, B., Cattaneo, E., Hackam, A., Sharp, A., Thornberry, N., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001475200 · Cited by 358
Brain-derived neurotrophic factor in Huntington disease
Ferrer, I., Goutan, E., Marı́n, C., Rey, M. J., & Ribalta, T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02237-x · Cited by 331
Bax Involvement in p53-Mediated Neuronal Cell Death
Xiang, H., Kinoshita, Y., Knudson, C. M., Korsmeyer, S. J., Schwartzkroin, P. A., & Morrison, R. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-04-01363.1998 · Cited by 330
Mouse models of Huntington's disease
Menalled, L. B., & Chesselet, M.-F. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01884-8 · Cited by 315
Law, A. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00051-5 · Cited by 314
Gervais, F. G., Singaraja, R., Xanthoudakis, S., Gutekunst, C.-A., Leavitt, B. R., Metzler, M., Hackam, A. S., Tam, J., Vaillancourt, J. P., Houtzager, V., et al. (2002) · Nature Cell Biology · doi:10.1038/ncb735 · Cited by 311
Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins
Hoffstrom, B. G., Kaplan, A., Letso, R., Schmid, R. S., Turmel, G. J., Lo, D. C., & Stockwell, B. R. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.467 · Cited by 310
Keene, C. D., Rodrigues, C. M. P., Eich, T., Chhabra, M. S., Steer, C. J., & Low, W. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162362299 · Cited by 306
Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases
Alexi, T. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00032-5 · Cited by 295
Programmed cell deaths: Apoptosis and alternative deathstyles
Assunção Guimarães, C., & Linden, R. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04084.x · Cited by 289
Mitochondria in Neurodegeneration: Bioenergetic Function in Cell Life and Death
Murphy, A. N., Fiskum, G., & Beal, M. F. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199903000-00001 · Cited by 288
Parent, J. M., Tada, E., Fike, J. R., & Lowenstein, D. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04508.1999 · Cited by 287
Apoptosis, Excitotoxicity, and Neuropathology
Leist, M., & Nicotera, P. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.4026 · Cited by 286
The mitochondrial death pathway: a promising therapeutic target in diseases
Gupta, S., Kass, G. E. N., Szegezdi, E., & Joseph, B. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00697.x · Cited by 278
Mechanisms of Neuronal Death in Alzheimer's Disease
Cotman, C. W., & Su, J. H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00878.x · Cited by 275
ICE/CED3-like Proteases as Therapeutic Targets for the Control of Inappropriate Apoptosis
Nicholson, D. W. (1996) · Nature Biotechnology · doi:10.1038/nbt0396-297 · Cited by 265
Mutant Huntingtin Causes Context-Dependent Neurodegeneration in Mice with Huntington's Disease
Yu, Z.-X., Li, S.-H., Evans, J., Pillarisetti, A., Li, H., & Li, X.-J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02193.2003 · Cited by 262
Apoptosis and neurologic disease
Honig, L. S., & Rosenberg, R. N. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00291-6 · Cited by 261
Genetics and Neuropathology of Huntington's Disease
Reiner, A., Dragatsis, I., & Dietrich, P. (2011) · International Review of Neurobiology · doi:10.1016/b978-0-12-381328-2.00014-6 · Cited by 261
Apoptosis in neurodegenerative diseases: the role of mitochondria
Tatton, W. G., & Olanow, C. W. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00167-4 · Cited by 257
Caspase-3 in the central nervous system: beyond apoptosis
D’Amelio, M., Sheng, M., & Cecconi, F. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.06.004 · Cited by 253
DNA strand breaks in Alzheimer’s disease
Adamec, E., Vonsattel, J. P., & Nixon, R. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02004-1 · Cited by 167
MFG-E8 regulates microglial phagocytosis of apoptotic neurons
Fuller, A. D., & Van Eldik, L. J. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9118-2 · Cited by 130
The Dorsal Root Ganglia in Adrenomyeloneuropathy: Neuronal Atrophy and Abnormal Mitochondria
Powers, J. M., Deciero, D. P., Cox, C., Richfield, E. K., Ito, M., Moser, A. B., & Moser, H. W. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.5.493 · Cited by 96
Self-citationMechanisms of cell death in Alzheimer’s disease
Bancher, C., Lassmann, H., Breitschopf, H., & Jellinger, K. A. (1997) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-6842-4_14 · Cited by 50
Metadata
- Authors
- Thomas, L. B., Gates, D. J., Richfield, E. K., O'Brien, T. F., Schweitzer, J. B., & Steindler, D. A.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 1995-06
- Volume
- 133
- Issue
- 2
- Pages
- 265-272
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2087077651
- Cited by
- 224
- References
- 0
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.